The Effect of Education Given on Preventing Mouth Ulcers in Women With Breast Cancer
1 other identifier
interventional
85
1 country
1
Brief Summary
This study aims to evaluate the effect of nursing education provided to women diagnosed with breast cancer undergoing chemotherapy on their quality of life and the severity of oral mucositis (mouth sores). The main questions this study aims to answer are:
- 1.Does nursing education aimed at preventing oral mucositis in women diagnosed with breast cancer have an effect on quality of life?
- 2.Does nursing education aimed at preventing oral mucositis in women diagnosed with breast cancer have an effect on the severity of oral mucositis? The researchers will evaluate the effect of nursing education on quality of life and oral mucositis severity by randomly assigning one group to receive education and the other group to not receive education.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2023
CompletedFirst Submitted
Initial submission to the registry
June 17, 2025
CompletedFirst Posted
Study publicly available on registry
June 29, 2025
CompletedJune 29, 2025
June 1, 2025
4 months
June 17, 2025
June 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of general health, functional and symptom-related quality of life (QLQ-C30), WHO oral toxicity criteria and ADR measurement scores within and between the intervention and control groups
The European Organisation for Research and Treatment of Cancer QLQ-C30 Version 3.0 Quality of Life Scale consists of a total of 30 questions divided into three subscales: general well-being, functional scale, and symptom scale. In this scale developed by the WHO, stage 0 represents normal oral mucosa, while stage 4 represents the highest severity of oral mucositis. The Oral Assessment Guide (OAG) covers eight areas: voice, swallowing, tongue, lips, oral mucosa, saliva, gums, and teeth/dentures. When calculating the final total oral mucosa score, the scores obtained from these eight areas are added together. The lowest score is 8, and the highest score is 24. An increase in the score indicates an increase in the severity of oral mucositis, while a decrease indicates a decrease in the severity of oral mucositis.
First day and 21st day
Study Arms (2)
Intervention (Education + Telephone consultation)
EXPERIMENTALControl group
NO INTERVENTIONThey continued to receive routine nursing care.
Interventions
The intervention group was trained on the use of the Oral Mucositis Prevention Patient Education Handbook, which was prepared by the researchers based on literature information and expert opinions. Participants in the intervention group received telephone consultations on days 7 and 14. The control group continued to receive routine nursing care. The second interview was completed on day 21, when both the intervention and control group patients returned for their next treatment cycle, using the WHO Oral Toxicity Criteria, ADR, and EORTC QLQ-C30 Version 3.0 Quality of Life Scale.
Eligibility Criteria
You may qualify if:
- Women diagnosed with breast cancer and undergoing chemotherapy,
- Aged 18 or older,
- Volunteering to participate in the study,
- Able to communicate, read and write in Turkish,
- With at least 3 weeks of chemotherapy treatment remaining
You may not qualify if:
- Having a known psychiatric illness that could interfere with the intervention and data collection process,
- Receiving chemo-radiotherapy,
- Having cognitive, perceptual, or communication issues that may affect their ability to understand the provided education.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Balkan Oncology Hospital affiliated with Trakya University Hospital, Trakya University, Republic of Turkey
Edirne, 22030, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
June 17, 2025
First Posted
June 29, 2025
Study Start
February 13, 2023
Primary Completion
June 15, 2023
Study Completion
August 15, 2023
Last Updated
June 29, 2025
Record last verified: 2025-06